After Hours Summary: ALT falls -10.5% after FDA issues clinical hold on AdCOVID; MIC jumps +4.1% after declaring one-time dividend of $11/shAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: FFHL +8.7% (gets bid to sell its Dornier production line), HCAP +7.7% (PTMN to merge with HCAP), MIC +4.1% (declares one-time dividend of $11 per share), AFYA +2.1% (approves share buyback program), CLDR +2% (closes on $500 mln debt issuance and the repurchase of Intel's stake in the co for $314 mln), ACI +1.9% (administers first doses of vaccine and is preparing for high consumer demand, hiring pharmacy staff), MGI +1.3% (issues statement on lawsuit filed by SEC against Ripple Labs; says it has not been made aware of any negative impact to its commercial agreement with Ripple), DM +1.2% (stock offering), BUD +1.2% (APO to acquire 49.9% stake in BUD's US-based metal container plants for $3 bln), PTMN +1.1% (PTMN to merge with HCAP), FSP +1% (announces sale of property in Durham, NC), TFC +0.9% (authorizes $2 bln stock repurchase plan following Fed stress test, will maintain dividend), DS +0.7% (files for $500 mln mixed securities shelf offering), EPZM +0.2% (Boehringer Ingelheim terminates collaboration with Epizyme), X +0.2% (sells Keystone Industrial Port Complex for $160 mln), PFE +0.1% (awarded a $2.01 bln US Army contract for the production of vaccine BNT162b2), BHVN +0.1% (stock offering)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: ALT -10.5% (FDA has issued a clinical hold on its IND application for AdCOVID), DRTT -4.8% (files for $100 mln mixed securities shelf offering), VRCA -3.8% (resubmits NDA for VP-102 for the treatment of molluscum), AFMD -3.3% (files for $225 mln mixed securities shelf offering), BLU -2.9% (stock offering), TXG -1.1% (to Present at JP Morgan Healthcare Conference), TRQ -1% (evaluating tax assessment from the Mongolian Tax Authority), MRNA -0.8% (co expects its vaccine will protect against new UK Covid variant, according to CNBC tweet), UROV -0.4% (FDA approves NDA for GEMTESA), SHO -0.1% (completes a series of balance sheet enhancing transactions), TAC -0.1% (announces 6% increase to dividend, and announces sale of assets to TransAlta Renewables)